Aktie 903982 9342-8530 QUÉBEC INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen 9342-8530 Québec Inc. Other OTC

Aktien

903982

CA2519121016

DGCRF

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
DiagnoCure Announces Resignation of Frederic Boivin as Interim CFO, Effective March 28, 2016
DiagnoCure, Inc. Reports Consolidated Earnings Results for the First Quarter Ended January 31, 2016
Gen-Probe Incorporated completed the acquisition of assets related to PCA3 prostate cancer biomarker from DiagnoCure Inc..
DiagnoCure Inc. Announces Earnings Results for the Fourth Quarter and Full Year Ended October 31, 2015; Reports Impairment of Intangible Asset for the Fourth Quarter Ended October 31, 2015
Gen-Probe Incorporated entered into an asset purchase agreement to acquire all assets related to PCA3 prostate cancer biomarker from DiagnoCure Inc. for CAD 6.5 million.
DiagnoCure Inc. Reports Earnings Results for the Third Quarter Ended July 31, 2015
DiagnoCure Inc. Announces Earnings Results for the Six Months Ended April 30, 2015
DiagnoCure, Inc. Reports Earnings Results for the Second Quarter Ended April 30, 2015
DiagnoCure Inc. Announces Board Changes
DiagnoCure, Inc. Reports Consolidated Financial Results for the First Quarter Ended January 31, 2015
DiagnoCure Inc. Announces Earnings Results for the Fourth Quarter and Fiscal Year Ended October 31, 2014
DiagnoCure Inc. Reports Consolidated Earnings Results for the Third Quarter Ended July 31, 2014
DiagnoCure Inc. Announces Earnings Results for the Six Months Ended April 30, 2014
DiagnoCure Inc. Announces Earnings Results for the Second Quarter Ended April 30, 2014
DiagnoCure, Inc. Reports Consolidated Earnings Results for the First Quarter Ended January 31, 2014
DiagnoCure, Inc. Reports Earnings Results for the Fourth Quarter 2013 and Fiscal Year Ended October 31, 2013
DiagnoCure Inc. Announces Resignation of Chantal Miklosi as CFO Effective October 11, 2013
DiagnoCure Inc. Announces Earnings Results for the Third Quarter Ended July 31, 2013
DiagnoCure Inc. Appoints Richard Bordeleau as Senior Advisor, Effective September 1, 2013
DiagnoCure Inc. Announces Earnings Results for the Second Quarter Ended April 30, 2013
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 903982 Aktie
  4. 903982 Aktie
  5. Nachrichten 9342-8530 Québec Inc.
  6. Andere Sprachen